Chloroprocaine Hydrochloride Injection, Solution
NDC Package 84549-209-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Chloroprocaine Hydrochloride injection is 2% and 3%, in single dose vials, without methylparaben preservative, without EDTA, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks.Chloroprocaine hydrochloride injection is not to be used for subarachnoid administration. This formulation utilizes a injection, solution delivery system. Marketed by Propharma Distribution, this product is identified by NDC 84549-209 and is authorized under FDA application ANDA040273.

Identification & Billing

NDC Package Code
84549-209-10
Package Description
20 mL in 1 VIAL
Product Code
11-Digit Billing Format
84549020910
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Chloroprocaine Hydrochloride
Non-Proprietary Name
Chloroprocaine Hydrochloride
Substance Name
Chloroprocaine Hydrochloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Epidural - Administration upon or over the dura mater.
  • Infiltration - Administration that results in substances passing into tissue spaces or into cells.
  • Intracaudal - Administration within the cauda equina.
  • Perineural - Administration surrounding a nerve or nerves.
Usage Information
Chloroprocaine hydrochloride injection 2% and 3%, in single dose vials, without methylparaben preservative, without EDTA, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks.Chloroprocaine hydrochloride injection is not to be used for subarachnoid administration.

Regulatory & Marketing

Labeler Name
Propharma Distribution
Product Type
Human Prescription Drug
FDA Application #
ANDA040273
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-01-1998
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84549-209-10 identifies a specific commercial package of 20 ml in 1 vial of Chloroprocaine Hydrochloride, a human prescription drug labeled by Propharma Distribution. This injection, solution is formulated for epidural; infiltration; intracaudal; perineural use and contains chloroprocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Propharma Distribution on November 01, 1998. The current certification is valid through December 31, 2026.

How is this Propharma Distribution product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84549020910. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84549-209-10
11-Digit CMS (5-4-2)
84549-0209-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.